Abbott Laboratories Overview
Abbott Laboratories Target Price
Analysts' 12-month price predictions for ABT.
Get informed when a big investor buys or sells
+ FollowShare Price
$95.39
Average Target Price
$126.86
33% upside
33% upside7 analysts in the last 4 months
High: $158 | Low: $92
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-22 | Daiwa | $92 |  3.6% downside |  |
| 2026-04-20 | BarclaysMatt Miksic | $143 | 49.9% upside | |
| 2026-04-17 | Stifel Nicolaus | $120 | 25.8% upside | |
| 2026-04-17 | Piper Sandler | $115 | 20.6% upside | |
| 2026-04-17 | UBS | $115 | 20.6% upside | |
| 2026-03-13 | New Street | $145 | 52% upside | |
| 2026-03-13 | UBSDanielle Antalffy | $158 | 65.6% upside | |
| 2026-02-02 | Barclays | $142 | 48.9% upside | |
| 2026-01-29 | Loop Capital MarketsIlya Zubkov | $120 | 25.8% upside | |
| 2026-01-23 | Evercore ISI | $138 | 44.7% upside | |
| 2026-01-23 | Mizuho SecuritiesAnthony Petrone | $125 | 31% upside | |
| 2026-01-23 | Piper Sandler | $135 | 41.5% upside | |
| 2026-01-23 | Bernstein | $125 | 31% upside | |
| 2026-01-23 | Wells FargoLarry Biegelsen | $122 | 27.9% upside | |
| 2026-01-23 | UBS | $132 | 38.4% upside | |
| 2026-01-09 | Goldman Sachs | $152 | 59.3% upside | |
| 2026-01-09 | BernsteinLee Hambright | $154 | 61.4% upside | |
| 2026-01-05 | Barclays | $169 | 77.2% upside | |
| 2026-01-05 | Evercore ISI | $144 | 51% upside | |
| 2025-12-22 | BTIGMarie Thibault | $145 | 52% upside | |
| 2025-11-21 | Tigress Financial | $145 | 52% upside | |
| 2025-10-17 | Barclays | $162 | 69.8% upside | |
| 2025-10-16 | Wells Fargo | $146 | 53.1% upside | |
| 2025-10-01 | Goldman Sachs | $157 | 64.6% upside | |
| 2025-07-15 | RBC CapitalShagun Singh | $147 | 54.1% upside | |
| 2025-04-15 | RBC CapitalShagun Singh | $140 | 46.8% upside | |
| 2025-01-08 | BernsteinLee Hambright | $135 | 41.5% upside | |
| 2024-10-17 | Piper SandlerAdam Maeder | $133 | 39.4% upside | |
| 2024-10-17 | BernsteinLee Hambright | $138 | 44.7% upside | |
| 2024-10-16 | JefferiesMatthew Taylor | $125 | 31% upside | |
| 2024-10-16 | BTIGMarie Thibault | $139 | 45.7% upside | |
| 2024-10-16 | Evercore ISIVijay Kumar | $128 | 34.2% upside | |
| 2024-10-08 | RBC CapitalShagun Singh | $130 | 36.3% upside | |
| 2024-10-08 | SusquehannaCharles Minervino | $120 | 25.8% upside | |
| 2024-10-08 | OppenheimerSuraj Kalia | $130 | 36.3% upside | |
| 2024-09-19 | Piper SandlerAdam Maeder | $131 | 37.3% upside | |
| 2024-09-19 | RBC CapitalJonathan Atkin | $165.65 | 73.7% upside | |
| 2024-09-19 | Roth CapitalScott Fortune | $24.01 | 74.8% downside | |
| 2024-08-27 | JefferiesMatthew Taylor | $120 | 25.8% upside | |
| 2024-08-22 | CitigroupJoanne Wuensch | $127 | 33.1% upside | |
| 2024-07-18 | Raymond JamesJayson Bedford | $127 | 33.1% upside | |
| 2024-07-18 | CitigroupJoanna Wiensch | $119 | 24.8% upside | |
| 2024-07-02 | Evercore ISIVijay Kumar | $120 | 25.8% upside | |
| 2024-06-03 | BTIGMarie Thibault | $135 | 41.5% upside | |
| 2024-05-30 | Goldman SachsDavid Roman | $121 | 26.8% upside | |
| 2024-04-22 | BarclaysMatt Miksic | $140 | 46.8% upside | |
| 2024-04-18 | RBC CapitalShagun Singh | $125 | 31% upside | |
| 2024-04-18 | BernsteinLee Hambright | $133 | 39.4% upside | |
| 2023-01-06 | Morgan Stanley | $133 | 39.4% upside | |
| 2022-12-12 | Citigroup | $125 | 31% upside | |